Agalioti, Theodora
Giannou, Anastasios D.
Krontira, Anthi C.
Kanellakis, Nikolaos I.
Kati, Danai
Vreka, Malamati
Pepe, Mario
Spella, Magda
Lilis, Ioannis
Zazara, Dimitra E.
Nikolouli, Eirini
Spiropoulou, Nikolitsa
Papadakis, Andreas
Papadia, Konstantina
Voulgaridis, Apostolos
Harokopos, Vaggelis
Stamou, Panagiota
Meiners, Silke
Eickelberg, Oliver
Snyder, Linda A.
Antimisiaris, Sophia G.
Kardamakis, Dimitrios
Psallidas, Ioannis
Marazioti, Antonia
Stathopoulos, Georgios T. http://orcid.org/0000-0002-9215-6461
Article History
Received: 20 May 2016
Accepted: 8 March 2017
First Online: 16 May 2017
Competing interests
: L.A.S. is an employee of the company that produces the anti-CCL2 antibodies. The remaining authors declare no competing financial interests.